Want to take your digital art to the next level by blending 3D objects seamlessly into 2D environments using Photoshop? This ...

As artificial intelligence transforms the economy and creates new winners, companies that don’t adopt the technology fast enough face the risk of being left behind. Christine Ji is a reporter covering ...

Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million funding in a bid to revolutionize AI drug design. According to Bloomberg, the ...

Designers and marketers globally are using Adobe Firefly for generative image creation, Substance 3D for photorealistic modeling and digital twins, Express for rapid on-brand content production, and ...

3D cell models offer a more physiologically relevant environment than traditional 2D cultures, making them a preferred option for modern drug discovery workflows. However, adapting high-throughput ...

Experts at the Table: Semiconductor Engineering sat down to discuss 3D-IC design challenges and the impact on stacked die on EDA tools and methodologies, with John Ferguson, senior director of product ...

Researchers at Harvard Medical School developed a tool that uses artificial intelligence to accelerate drug discovery and development. The new technology, called PDGrapher, applies machine learning to ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Have you ever imagined turning your ideas into physical objects with just a few clicks? Thanks to tools like Tinkercad, what once seemed like science fiction is now an accessible reality for anyone ...

FRANKFORT, Ky. (WOWK) — Kentucky Governor Andy Beshear announced on Monday that bromazolam, also known as “Designer Xanax,” received an emergency designation as a Schedule I controlled substance. As a ...